4th July 2019

Shooting Athlete Suspended for the Presence of Hydrochlorothiazide

The Canadian Centre for Ethics in Sport (CCES) announced today that Amanda Chudoba Obrigewitch, a shooting athlete, received a one-month sanction for an anti-doping rule violation. The athlete’s urine sample, collected during in-competition doping control on May 18, 2019, revealed the presence of hydrochlorothiazide, a prohibited diuretic and masking agent.

Hydrochlorothiazide is classified as a “specified substance” on the Prohibited List. Under the rules of the Canadian Anti-Doping Program (CADP), an athlete facing a first violation involving a “specified substance” will be given a proposed sanction based on the CCES’s assessment of the athlete’s degree of fault. In this case, the CCES proposed a one-month period of ineligibility.

In response to the CCES’s notification of the adverse analytical finding, Ms. Chudoba Obrigewitch admitted the violation in a timely fashion (in accordance with CADP rule 10.11.2), waived her right to a hearing and accepted the proposed sanction, which terminates on July 5, 2019. During the sanction period, the athlete, who resides in Spruce Grove, Alberta, is ineligible to participate in any capacity with any sport signatory to the CADP, including training with teammates. In compliance with rule 7.10 of the CADP, the CCES’s file outcome summary can be found in the Canadian Sport Sanction Registry.

• This media release was published by the Canadian Centre for Ethics in Sport (CCES) on 4 July 2019. Click here for the original.

You may also like...

Pin It on Pinterest

Share This